A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC
NCT06823050
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Sponsor
Xuhua Duan